Antihypertensive effects of tolamolol
- PMID: 318950
- DOI: 10.1002/cpt19772119
Antihypertensive effects of tolamolol
Abstract
The antihypertensive and renin-lowering efficacy and side effects of tolamolol, a beta adrenergic blocking drug with cardioselectivity, were examined in 10 patients with mild essential hypertension while on regular diet. Tolamol, at a dose of 300 to 900 mg per day, given over a period of 2 to 4 wk significantly decreased systolic and diastolic blood pressures in both the recumbent and standing positions. Normal blood pressure (140/90 mm Hg or less) was attained in 8 subjects. Mean heart rate and ambulatory midday plasma renin activity (PRA) decreased significantly; however, there was no significant correlation between blood pressure decrease and either the pretreatment PRA or decrease in PRA. Body weight did not change significantly. No adverse side effects were detected and no changes in the liver or renal function or in the blood count were observed. It is concluded that tolamolol is effective in lowering blood pressure and PRA in patients with hypertension.
Similar articles
-
Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.Clin Pharmacol Ther. 1979 Mar;25(3):294-302. doi: 10.1002/cpt1979253294. Clin Pharmacol Ther. 1979. PMID: 367678 Clinical Trial.
-
Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.Chest. 1978 Jun;73(6):807-12. doi: 10.1378/chest.73.6.807. Chest. 1978. PMID: 350512 Clinical Trial.
-
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.Eur J Clin Pharmacol. 1977 Mar 11;11(3):159-62. doi: 10.1007/BF00606404. Eur J Clin Pharmacol. 1977. PMID: 323023 Clinical Trial.
-
Once-daily metoprolol in primary hypertension.Clin Pharmacol Ther. 1979 Apr;25(4):399-407. doi: 10.1002/cpt1979254399. Clin Pharmacol Ther. 1979. PMID: 371902 Clinical Trial.
-
Effects of metoprolol on blood pressure and plasma renin activity in thiazide-resistant hypertensive patients.Clin Pharmacol Ther. 1979 Nov;26(5):555-61. doi: 10.1002/cpt1979265555. Clin Pharmacol Ther. 1979. PMID: 498696
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials